Dr. Samir Mehta, MD

Dr. Mehta practices at Good Shepherd Penn Partners - HOPD (3737 Market St, 2nd Fl) in Philadelphia, Pennsylvania.

Dr. Mehta's NPI, 1003851817, was assigned on June 17, 2006. Dr. Mehta graduated from Temple University School of Medicine in 2000. Dr. Mehta holds Pennsylvania license MD420022.

Dr. Mehta's primary practice is Good Shepherd Penn Partners - HOPD (3737 Market St, 2nd Fl), at 3737 Market St, 2nd Fl, Philadelphia, PA 19104.

Dr. Mehta's primary practice is Good Shepherd Penn Partners - HOPD (3737 Market St, 2nd Fl) in Philadelphia, Pennsylvania. Dr. Mehta is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Mehta to 3 more hospitals, 2 group practices and clinics, 2 home health agencies, 1 breast imaging center, 1 ambulatory surgery center and 1 medical group, each named with a free account. Dr. Mehta's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 11 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Mehta's licenses on file in 2 states: Pennsylvania and New Jersey.

CMS data shows 427 Medicare services from Dr. Mehta across 6 procedure codes in 2024, for 319 Medicare patients. Medicare paid $52,369 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 319 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 132 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 52, with 54% women.

In 2024, Dr. Mehta wrote 13 Medicare Part D claims. 100% of them were for generic drugs. They cover 3 drugs, with $875 in total drug cost. In 2020, CMS named 41 claims across 3 drugs.

Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 217 papers to Dr. Mehta, published from 2010 to 2025. 2023 was the busiest year, with 16. The most frequent topics are Fracture Fixation, Internal, Fractures, Bone and Orthopedics. Dr. Mehta has published most often in J Orthop Trauma. Dr. Mehta's most frequent co-authors are Keith Douglas Baldwin, MD, Robert D. Zura, MD and Gregory John Della Rocca, MD.

Dmand AI links Dr. Mehta to 3 clinical trials. Conditions studied include Bisphosphonate-Associated Osteonecrosis of the Jaw, Osteomyelitis and Bone Diseases, Infectious. University of Pennsylvania sponsors the most, 2.

CMS Open Payments shows 1,191 general payments to Dr. Mehta from 48 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 74% of the total. Smith & Nephew, Inc. paid the most, $2,727,008.

Dr. Mehta graduated from Temple University School of Medicine in 2000.